Here’s what you need to know:
1. Net sales were $287 million, representing a 3.2 percent growth.
2. Net sales for the bracing and vascular segment were $134.4 million, representing a 0.9 percent growth.
3. Net sales for the recovery sciences segment were $39.8 million, representing a 5 percent growth.
4. Net sales for the surgical implant segment were $40.9 million, representing an 8.5 percent growth.
5. The company reported a net loss of $22.6 million, which compares to a net loss of $177.8 million for the third quarter of 2015.
More articles on devices and implants:
Mazor Robotics sees 52% revenue boost in Q3 2016: 14 report highlights
SeaSpine earns FDA clearance for Mariner Posterior Fixation System: 5 highlights
Where do our nation’s politicians stand on the medical device tax?
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
